BioNotebook: Dendreon, Anacor/Valeant, GlycoMimetics, Karyopharm, Cellceutix
This article was originally published in Scrip
Executive Summary
Dendreon reportedly seeks buyer; Anacor, Valeant settle; GlycoMimetics, Karyopharm set IPO terms; and Cellceutix raises funds in stock deal with Aspire Capital.